Becton Dickinson EMEA revenue
EMEA revenue at Becton Dickinson came to $4.7B for the fiscal year to 30 Sep 2025, up 7.4% from a year earlier.
As Becton Dickinson reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 25 Nov 2025.
By fiscal year
| Period ending | EMEA revenue | Change on a year | Filed |
|---|---|---|---|
| 30 Sep 2025 | $4.7B | up 7.4% | 25 Nov 2025 |
| 30 Sep 2024 | $4.4B | up 3.7% | 27 Nov 2024 |
| 30 Sep 2023 | $4.2B | up 5.0% | 21 Nov 2023 |
| 30 Sep 2022 | $4.0B | down 11.1% | 22 Nov 2022 |
| 30 Sep 2021 | $4.5B | up 21.8% | 24 Nov 2021 |
| 30 Sep 2020 | $3.7B | down 2.7% | 25 Nov 2020 |
| 30 Sep 2019 | $3.8B | — | 27 Nov 2019 |
Definition
Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.
Other operating KPIs of Becton Dickinson: Medical revenue · Medical Essentials revenue · Interventional revenue · Life Sciences (earlier basis) revenue · Connected Care revenue · BioPharma Systems revenue · Greater Asia revenue · United States revenue · International revenue · financial statements
Every KPI and segment of BDX, in the terminal.
Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.
